id: telemedicine_use_to_NEW:quality_of_life_diabetes
name: Telemedicine Use â†’ Quality of Life (Non-Youth-Specific)
from_node:
  node_id: telemedicine_use
  node_name: Telemedicine Use
to_node:
  node_id: NEW:quality_of_life_diabetes
  node_name: Quality of Life (Non-Youth-Specific)
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Telemedicine interventions provide remote access to diabetes care providers,
  enabling more frequent monitoring and communication between patients and healthcare
  teams'
- 'Step 2: Enhanced monitoring facilitates timely medication dose adjustments and
  personalized diabetes management guidance, improving glycemic control (HbA1c reduction
  of 0.22%)'
- 'Step 3: Improved glycemic control reduces diabetes-related symptoms, complications,
  and daily disease burden'
- 'Step 4: Reduced disease burden and better diabetes management translate to improved
  overall quality of life as measured by non-youth-specific instruments'
evidence:
  quality_rating: A
  n_studies: 20
  primary_citation: 'Kun Zhang et al. 2023. Telemedicine in Improving Glycemic Control
    Among Children and Adolescents With Type 1 Diabetes Mellitus: Systematic Review
    and Meta-Analysis. Journal of Medical Internet Research.'
  supporting_citations: []
description: Meta-analysis of 20 RCTs (n=1704) demonstrates that telemedicine interventions
  significantly improve non-youth-specific quality of life in children and adolescents
  with Type 1 diabetes mellitus compared to usual care. The improvement in quality
  of life appears to be mediated through better glycemic control achieved via enhanced
  remote monitoring, more frequent provider communication, and timely treatment adjustments.
  Notably, while youth-specific diabetes quality of life scores showed no significant
  improvement, general quality of life measures demonstrated statistically significant
  benefits with no heterogeneity across studies.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: -0.24
    type: mean_difference
    ci_lower: -0.45
    ci_upper: -0.02
  p_value: 0.04
  sample_size: 1704
moderators:
- name: Age group
  direction: strengthens
  strength: moderate
  description: Effects on HbA1c appeared greater in studies involving children compared
    to adolescents (MD -0.41 vs overall -0.22)
- name: Study duration
  direction: strengthens
  strength: moderate
  description: Studies lasting less than 6 months showed greater effects (MD -0.32)
    compared to longer studies
- name: Communication modality
  direction: strengthens
  strength: strong
  description: Studies using smartphone apps for provider-patient communication showed
    stronger effects (MD -0.37)
- name: Medication dose adjustment
  direction: strengthens
  strength: moderate
  description: Studies incorporating medication dose adjustment showed enhanced effects
    (MD -0.25)
